Reuters Update 1-Drugmaker Teva Does Not See Big Impact on Business from Israel-Hamas War Morningstar Teva to Host Conference Call to Discuss Third Quarter...
reuters
UPDATE 1-Drugmaker Teva does not see big impact on business from Israel-Hamas war
Teva Takes A Run At Its 200-Day Line After Second-Quarter Beat And Raise
businesswire
Teva Reports Second Quarter 2023 Financial Results
businesswire
Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development
morningstar
Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
markets.ft
Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023
duckduckgo
Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine
barrons
Patients Can’t Get Some Lifesaving Drugs. What’s Causing the Shortages.
insidermonkey
11 Best Medical Stocks Under $10
fool
3 Bargain Stocks to Buy on the Dip
wsj
Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It